Archive for the ‘Imprimis Pharmaceuticals Inc’ Category

Imprimus Pharmaceuticals

October 23rd, 2015 | Posted in 2015, Imprimis Pharmaceuticals Inc

In an excellent show of corporate goodwill, a San Diego company is stepping into the furor over price spikes for old generic drugs. San Diego’s Imprimis Pharmaceuticals, a maker of compounded drugs, will begin selling doses of Daraprim for $1 per dose. Last month, a NY company purchased the generic drug and raised the price by 5000% […]

Imprimis Pharmaceuticals

August 7th, 2015 | Posted in 2015, Imprimis Pharmaceuticals Inc

San Diego’s Imprimis Pharmaceuticals acquired the rights to novel proprietary sedation and anesthesia/analgesia formulations that block pain and sedate patients undergoing ocular and other surgical procedures. The new compounded formulations may be available for prescription and dispensing sometime during the fall.

Imprimis Pharmaceuticals

November 26th, 2014 | Posted in 2014, Imprimis Pharmaceuticals Inc

Imprimus Pharmaceuticals, San Diego, has entered into a distribution agreement with MD Distributor Corp to market its Go Dropless formulations, patent pending, in Puerto Rico and other Caribbean countries.

Imprimis Pharmaceuticals Inc

December 4th, 2013 | Posted in 2013, Imprimis Pharmaceuticals Inc

Imprimis Pharmaceuticals Inc. – Is a pharmaceutical company focused on commercializing new novel drug formulations invented by physicians and pharmacists through their clinical experience with patents.  The company has hired John Saharek as V. P. of Commercialization for Ophthalmologists in the USA and abroad.